CN103764787A - 氟化苝基半导体材料 - Google Patents
氟化苝基半导体材料 Download PDFInfo
- Publication number
- CN103764787A CN103764787A CN201280037496.9A CN201280037496A CN103764787A CN 103764787 A CN103764787 A CN 103764787A CN 201280037496 A CN201280037496 A CN 201280037496A CN 103764787 A CN103764787 A CN 103764787A
- Authority
- CN
- China
- Prior art keywords
- substituent
- optionally
- alkyl
- replacing
- cor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004065 semiconductor Substances 0.000 title claims abstract description 26
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 title description 10
- 150000001875 compounds Chemical class 0.000 claims abstract description 30
- 125000001424 substituent group Chemical group 0.000 claims description 162
- 125000001072 heteroaryl group Chemical group 0.000 claims description 42
- 229910052736 halogen Inorganic materials 0.000 claims description 35
- 150000002367 halogens Chemical class 0.000 claims description 35
- 125000000217 alkyl group Chemical group 0.000 claims description 34
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 32
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims description 26
- 239000000463 material Substances 0.000 claims description 23
- 125000000739 C2-C30 alkenyl group Chemical group 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 11
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 5
- 229910052740 iodine Inorganic materials 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 239000002585 base Substances 0.000 description 93
- -1 tetracarboxylic acid imide compound Chemical class 0.000 description 47
- 229910052757 nitrogen Inorganic materials 0.000 description 13
- 230000005669 field effect Effects 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 11
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 10
- 239000000460 chlorine Substances 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000010931 gold Substances 0.000 description 6
- VRLIPUYDFBXWCH-UHFFFAOYSA-N hydridocarbon(.) Chemical compound [CH] VRLIPUYDFBXWCH-UHFFFAOYSA-N 0.000 description 6
- 150000003851 azoles Chemical class 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- WTQLBEFMMNQTCH-UHFFFAOYSA-N 1-carbamoylperylene-2,3,4-tricarboxylic acid Chemical compound C1=CC(C=2C(C(=N)O)=C(C(O)=O)C(C(O)=O)=C3C=2C2=CC=C3C(O)=O)=C3C2=CC=CC3=C1 WTQLBEFMMNQTCH-UHFFFAOYSA-N 0.000 description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 4
- 229960001866 silicon dioxide Drugs 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Divinylene sulfide Natural products C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 3
- 239000003989 dielectric material Substances 0.000 description 3
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 3
- HOWGUJZVBDQJKV-UHFFFAOYSA-N docosane Chemical compound CCCCCCCCCCCCCCCCCCCCCC HOWGUJZVBDQJKV-UHFFFAOYSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- YCOZIPAWZNQLMR-UHFFFAOYSA-N heptane - octane Natural products CCCCCCCCCCCCCCC YCOZIPAWZNQLMR-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- 229910052715 tantalum Inorganic materials 0.000 description 3
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 3
- 125000001399 1,2,3-triazolyl group Chemical class N1N=NC(=C1)* 0.000 description 2
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 description 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N 1-nonene Chemical compound CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 2
- OHZAHWOAMVVGEL-UHFFFAOYSA-N 2,2'-bithiophene Chemical group C1=CSC(C=2SC=CC=2)=C1 OHZAHWOAMVVGEL-UHFFFAOYSA-N 0.000 description 2
- XNMQEEKYCVKGBD-UHFFFAOYSA-N 2-butyne Chemical compound CC#CC XNMQEEKYCVKGBD-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- WLLGXSLBOPFWQV-UHFFFAOYSA-N MGK 264 Chemical compound C1=CC2CC1C1C2C(=O)N(CC(CC)CCCC)C1=O WLLGXSLBOPFWQV-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 239000004642 Polyimide Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 241000534944 Thia Species 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 239000000010 aprotic solvent Substances 0.000 description 2
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- UMIVXZPTRXBADB-UHFFFAOYSA-N benzocyclobutene Chemical compound C1=CC=C2CCC2=C1 UMIVXZPTRXBADB-UHFFFAOYSA-N 0.000 description 2
- 125000002837 carbocyclic group Chemical group 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- DMEGYFMYUHOHGS-UHFFFAOYSA-N cycloheptane Chemical compound C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 2
- ZVDBUOGYYYNMQI-UHFFFAOYSA-N dodec-1-yne Chemical compound CCCCCCCCCCC#C ZVDBUOGYYYNMQI-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- NDJKXXJCMXVBJW-UHFFFAOYSA-N heptadecane Chemical compound CCCCCCCCCCCCCCCCC NDJKXXJCMXVBJW-UHFFFAOYSA-N 0.000 description 2
- HMSWAIKSFDFLKN-UHFFFAOYSA-N hexacosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC HMSWAIKSFDFLKN-UHFFFAOYSA-N 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 2
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- LQERIDTXQFOHKA-UHFFFAOYSA-N nonadecane Chemical compound CCCCCCCCCCCCCCCCCCC LQERIDTXQFOHKA-UHFFFAOYSA-N 0.000 description 2
- RZJRJXONCZWCBN-UHFFFAOYSA-N octadecane Chemical compound CCCCCCCCCCCCCCCCCC RZJRJXONCZWCBN-UHFFFAOYSA-N 0.000 description 2
- 125000000962 organic group Chemical group 0.000 description 2
- 238000013086 organic photovoltaic Methods 0.000 description 2
- 125000000160 oxazolidinyl group Chemical group 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920001721 polyimide Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- POOSGDOYLQNASK-UHFFFAOYSA-N tetracosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC POOSGDOYLQNASK-UHFFFAOYSA-N 0.000 description 2
- BGHCVCJVXZWKCC-UHFFFAOYSA-N tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 description 2
- 229930192474 thiophene Natural products 0.000 description 2
- IIYFAKIEWZDVMP-UHFFFAOYSA-N tridecane Chemical compound CCCCCCCCCCCCC IIYFAKIEWZDVMP-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- SHAHPWSYJFYMRX-GDLCADMTSA-N (2S)-2-(4-{[(1R,2S)-2-hydroxycyclopentyl]methyl}phenyl)propanoic acid Chemical compound C1=CC([C@@H](C(O)=O)C)=CC=C1C[C@@H]1[C@@H](O)CCC1 SHAHPWSYJFYMRX-GDLCADMTSA-N 0.000 description 1
- WLWNRAWQDZRXMB-YLFCFFPRSA-N (2r,3r,4r,5s)-n,3,4,5-tetrahydroxy-1-(4-phenoxyphenyl)sulfonylpiperidine-2-carboxamide Chemical compound ONC(=O)[C@H]1[C@@H](O)[C@H](O)[C@@H](O)CN1S(=O)(=O)C(C=C1)=CC=C1OC1=CC=CC=C1 WLWNRAWQDZRXMB-YLFCFFPRSA-N 0.000 description 1
- 0 *N(C(c(c1c(c(-c(c(c2c3C(N4*)=O)c-5cc3F)cc(F)c2C4=O)c2)c-5cc(F)c11)c2F)=O)C1=O Chemical compound *N(C(c(c1c(c(-c(c(c2c3C(N4*)=O)c-5cc3F)cc(F)c2C4=O)c2)c-5cc(F)c11)c2F)=O)C1=O 0.000 description 1
- 125000004529 1,2,3-triazinyl group Chemical group N1=NN=C(C=C1)* 0.000 description 1
- 125000004530 1,2,4-triazinyl group Chemical group N1=NC(=NC=C1)* 0.000 description 1
- CSNIZNHTOVFARY-UHFFFAOYSA-N 1,2-benzothiazole Chemical compound C1=CC=C2C=NSC2=C1 CSNIZNHTOVFARY-UHFFFAOYSA-N 0.000 description 1
- 125000003363 1,3,5-triazinyl group Chemical class N1=C(N=CN=C1)* 0.000 description 1
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 description 1
- PLAWCFOMHQCJBK-UHFFFAOYSA-N 1-(2,2-dimethylpropylperoxy)pentane Chemical compound CCCCCOOCC(C)(C)C PLAWCFOMHQCJBK-UHFFFAOYSA-N 0.000 description 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- NQRACBRRMUBSDA-UHFFFAOYSA-N 17-azahexacyclo[10.9.2.02,7.03,19.08,23.015,22]tricosa-1(21),2(7),3,5,8,10,12(23),13,15(22),19-decaene-16,18-dione Chemical compound C12=CC=C3C=CC=C4C5=CC=CC=6C(=CC=C(C1=C34)C56)C(NC2=O)=O NQRACBRRMUBSDA-UHFFFAOYSA-N 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- OXBLVCZKDOZZOJ-UHFFFAOYSA-N 2,3-Dihydrothiophene Chemical compound C1CC=CS1 OXBLVCZKDOZZOJ-UHFFFAOYSA-N 0.000 description 1
- JKTCBAGSMQIFNL-UHFFFAOYSA-N 2,3-dihydrofuran Chemical compound C1CC=CO1 JKTCBAGSMQIFNL-UHFFFAOYSA-N 0.000 description 1
- 125000006031 2-methyl-3-butenyl group Chemical group 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
- 125000004364 3-pyrrolinyl group Chemical group [H]C1=C([H])C([H])([H])N(*)C1([H])[H] 0.000 description 1
- GUUULVAMQJLDSY-UHFFFAOYSA-N 4,5-dihydro-1,2-thiazole Chemical compound C1CC=NS1 GUUULVAMQJLDSY-UHFFFAOYSA-N 0.000 description 1
- 125000006416 CBr Chemical group BrC* 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- HECLRDQVFMWTQS-UHFFFAOYSA-N Dicyclopentadiene Chemical compound C1C2C3CC=CC3C1C=C2 HECLRDQVFMWTQS-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241000208202 Linaceae Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 229920001665 Poly-4-vinylphenol Polymers 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- MYSPGJLWEFWHCK-UHFFFAOYSA-N [O].C(CCCCCCCCC)OCCCCCCCCCCC Chemical compound [O].C(CCCCCCCCC)OCCCCCCCCCCC MYSPGJLWEFWHCK-UHFFFAOYSA-N 0.000 description 1
- GTZOZDOTOWNSJH-UHFFFAOYSA-N [O].CCCCCCC Chemical compound [O].CCCCCCC GTZOZDOTOWNSJH-UHFFFAOYSA-N 0.000 description 1
- CVYNBVMJLPTTFD-UHFFFAOYSA-N [O].CCCCCCCCCCCC Chemical compound [O].CCCCCCCCCCCC CVYNBVMJLPTTFD-UHFFFAOYSA-N 0.000 description 1
- CTTWWHABKOXFAB-UHFFFAOYSA-N [O].CCCCCCCCCCCCC Chemical compound [O].CCCCCCCCCCCCC CTTWWHABKOXFAB-UHFFFAOYSA-N 0.000 description 1
- WOUIKYKNZGCTCD-UHFFFAOYSA-N [O].CCCCCCCCCCCCCC Chemical compound [O].CCCCCCCCCCCCCC WOUIKYKNZGCTCD-UHFFFAOYSA-N 0.000 description 1
- MEWQFMZMPMAMTG-UHFFFAOYSA-N [O].CCCCCCCCCCCCCCC Chemical compound [O].CCCCCCCCCCCCCCC MEWQFMZMPMAMTG-UHFFFAOYSA-N 0.000 description 1
- PNNXBWWSFIVKQW-UHFFFAOYSA-N [O].CCCCCCCCCCCCCCCC Chemical compound [O].CCCCCCCCCCCCCCCC PNNXBWWSFIVKQW-UHFFFAOYSA-N 0.000 description 1
- FVXZXFWDTIMEMA-UHFFFAOYSA-N [O].CCCCCCCCCCCCCCCCC Chemical compound [O].CCCCCCCCCCCCCCCCC FVXZXFWDTIMEMA-UHFFFAOYSA-N 0.000 description 1
- CIGIRZIOSVQVKQ-UHFFFAOYSA-N [O].CCCCCCCCCCCCCCCCCC Chemical compound [O].CCCCCCCCCCCCCCCCCC CIGIRZIOSVQVKQ-UHFFFAOYSA-N 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000001118 alkylidene group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 238000006254 arylation reaction Methods 0.000 description 1
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 1
- 125000003725 azepanyl group Chemical group 0.000 description 1
- 125000002785 azepinyl group Chemical group 0.000 description 1
- MXMZCLLIUQEKSN-UHFFFAOYSA-N benzimidazoline Chemical compound C1=CC=C2NCNC2=C1 MXMZCLLIUQEKSN-UHFFFAOYSA-N 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004619 benzopyranyl group Chemical group O1C(C=CC2=C1C=CC=C2)* 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- MLIYPCQSOXNTLJ-UHFFFAOYSA-N carbon monoxide;ruthenium dihydride;triphenylphosphane Chemical compound [RuH2].[O+]#[C-].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 MLIYPCQSOXNTLJ-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000003016 chromanyl group Chemical group O1C(CCC2=CC=CC=C12)* 0.000 description 1
- 125000000259 cinnolinyl group Chemical class N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- IAQRGUVFOMOMEM-ARJAWSKDSA-N cis-but-2-ene Chemical compound C\C=C/C IAQRGUVFOMOMEM-ARJAWSKDSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229960003280 cupric chloride Drugs 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- CHVJITGCYZJHLR-UHFFFAOYSA-N cyclohepta-1,3,5-triene Chemical compound C1C=CC=CC=C1 CHVJITGCYZJHLR-UHFFFAOYSA-N 0.000 description 1
- 125000003678 cyclohexadienyl group Chemical group C1(=CC=CCC1)* 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000005070 decynyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C#C* 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 125000002576 diazepinyl group Chemical group N1N=C(C=CC=C1)* 0.000 description 1
- TXCDCPKCNAJMEE-UHFFFAOYSA-N dibenzofuran Chemical group C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- YVXHZKKCZYLQOP-UHFFFAOYSA-N hept-1-yne Chemical compound CCCCCC#C YVXHZKKCZYLQOP-UHFFFAOYSA-N 0.000 description 1
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- CBFCDTFDPHXCNY-UHFFFAOYSA-N icosane Chemical compound CCCCCCCCCCCCCCCCCCCC CBFCDTFDPHXCNY-UHFFFAOYSA-N 0.000 description 1
- 125000002636 imidazolinyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000005945 imidazopyridyl group Chemical group 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- MRNHPUHPBOKKQT-UHFFFAOYSA-N indium;tin;hydrate Chemical compound O.[In].[Sn] MRNHPUHPBOKKQT-UHFFFAOYSA-N 0.000 description 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- HOBCFUWDNJPFHB-UHFFFAOYSA-N indolizine Chemical compound C1=CC=CN2C=CC=C21 HOBCFUWDNJPFHB-UHFFFAOYSA-N 0.000 description 1
- 125000005990 isobenzothienyl group Chemical group 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000005644 linolenyl group Chemical group 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910001512 metal fluoride Inorganic materials 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000002819 montanyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 125000001802 myricyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- AFFLGGQVNFXPEV-UHFFFAOYSA-N n-decene Natural products CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 1
- 125000006608 n-octyloxy group Chemical group 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- OSSQSXOTMIGBCF-UHFFFAOYSA-N non-1-yne Chemical group CCCCCCCC#C OSSQSXOTMIGBCF-UHFFFAOYSA-N 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- IYDNQWWOZQLMRH-UHFFFAOYSA-N octadec-1-yne Chemical compound CCCCCCCCCCCCCCCCC#C IYDNQWWOZQLMRH-UHFFFAOYSA-N 0.000 description 1
- 229940038384 octadecane Drugs 0.000 description 1
- 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 125000003551 oxepanyl group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- SLIUAWYAILUBJU-UHFFFAOYSA-N pentacene Chemical compound C1=CC=CC2=CC3=CC4=CC5=CC=CC=C5C=C4C=C3C=C21 SLIUAWYAILUBJU-UHFFFAOYSA-N 0.000 description 1
- RFPMGSKVEAUNMZ-UHFFFAOYSA-N pentylidene Chemical group [CH2+]CCC[CH-] RFPMGSKVEAUNMZ-UHFFFAOYSA-N 0.000 description 1
- 125000005981 pentynyl group Chemical group 0.000 description 1
- WSRHMJYUEZHUCM-UHFFFAOYSA-N perylene-1,2,3,4-tetracarboxylic acid Chemical class C=12C3=CC=CC2=CC=CC=1C1=C(C(O)=O)C(C(O)=O)=C(C(O)=O)C2=C1C3=CC=C2C(=O)O WSRHMJYUEZHUCM-UHFFFAOYSA-N 0.000 description 1
- 125000005561 phenanthryl group Chemical group 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical compound C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 description 1
- PJGSXYOJTGTZAV-UHFFFAOYSA-N pinacolone Chemical compound CC(=O)C(C)(C)C PJGSXYOJTGTZAV-UHFFFAOYSA-N 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000002755 pyrazolinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- YEYHFKBVNARCNE-UHFFFAOYSA-N pyrido[2,3-b]pyrazine Chemical compound N1=CC=NC2=CC=CN=C21 YEYHFKBVNARCNE-UHFFFAOYSA-N 0.000 description 1
- BWESROVQGZSBRX-UHFFFAOYSA-N pyrido[3,2-d]pyrimidine Chemical compound C1=NC=NC2=CC=CN=C21 BWESROVQGZSBRX-UHFFFAOYSA-N 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000010129 solution processing Methods 0.000 description 1
- 150000000000 tetracarboxylic acids Chemical class 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000005958 tetrahydrothienyl group Chemical group 0.000 description 1
- 125000003698 tetramethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000005458 thianyl group Chemical group 0.000 description 1
- 125000005308 thiazepinyl group Chemical group S1N=C(C=CC=C1)* 0.000 description 1
- 125000004305 thiazinyl group Chemical group S1NC(=CC=C1)* 0.000 description 1
- 125000002769 thiazolinyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- DBDCNCCRPKTRSD-UHFFFAOYSA-N thieno[3,2-b]pyridine Chemical compound C1=CC=C2SC=CC2=N1 DBDCNCCRPKTRSD-UHFFFAOYSA-N 0.000 description 1
- 229940125670 thienopyridine Drugs 0.000 description 1
- 239000002175 thienopyridine Substances 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 125000001583 thiepanyl group Chemical group 0.000 description 1
- 125000003777 thiepinyl group Chemical group 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- IAQRGUVFOMOMEM-ONEGZZNKSA-N trans-but-2-ene Chemical compound C\C=C\C IAQRGUVFOMOMEM-ONEGZZNKSA-N 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B57/00—Other synthetic dyes of known constitution
- C09B57/08—Naphthalimide dyes; Phthalimide dyes
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K10/00—Organic devices specially adapted for rectifying, amplifying, oscillating or switching; Organic capacitors or resistors having a potential-jump barrier or a surface barrier
- H10K10/40—Organic transistors
- H10K10/46—Field-effect transistors, e.g. organic thin-film transistors [OTFT]
- H10K10/462—Insulated gate field-effect transistors [IGFETs]
- H10K10/484—Insulated gate field-effect transistors [IGFETs] characterised by the channel regions
- H10K10/486—Insulated gate field-effect transistors [IGFETs] characterised by the channel regions the channel region comprising two or more active layers, e.g. forming pn heterojunctions
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/615—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
- H10K85/621—Aromatic anhydride or imide compounds, e.g. perylene tetra-carboxylic dianhydride or perylene tetracarboxylic di-imide
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K10/00—Organic devices specially adapted for rectifying, amplifying, oscillating or switching; Organic capacitors or resistors having a potential-jump barrier or a surface barrier
- H10K10/40—Organic transistors
- H10K10/46—Field-effect transistors, e.g. organic thin-film transistors [OTFT]
- H10K10/462—Insulated gate field-effect transistors [IGFETs]
- H10K10/464—Lateral top-gate IGFETs comprising only a single gate
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K10/00—Organic devices specially adapted for rectifying, amplifying, oscillating or switching; Organic capacitors or resistors having a potential-jump barrier or a surface barrier
- H10K10/40—Organic transistors
- H10K10/46—Field-effect transistors, e.g. organic thin-film transistors [OTFT]
- H10K10/462—Insulated gate field-effect transistors [IGFETs]
- H10K10/466—Lateral bottom-gate IGFETs comprising only a single gate
Abstract
本发明提供了一种式(1)化合物。式(1)化合物适于用作半导体材料,尤其是用于电子器件中。
Description
有机半导体材料可用于电子器件如有机光伏(OPV)电池、有机场效应晶体管(OFET)和有机发光二极管(OLED)中。
就高效和长期性能而言,希望有机半导体材料基器件在环境条件下具有高载流子迁移率和高稳定性,尤其是对氧化而言。
此外,希望有机半导体材料与液体加工技术相容,这是因为液体加工技术就加工性角度而言是便利的,因此允许生产低成本有机半导体材料基电子器件。此外,液体加工技术也与塑料衬底相容,由此允许生产轻质和柔性的有机半导体材料基电子器件。
适用于电子器件中的苝二酰亚胺基有机半导体材料是本领域所已知的。
R.Schmidt,J.H.Oh,Y.-S.Sun,M.Deppisch,A.-M.Krause,K.Radacki,H.Braunschweig,M.,P.Erk,Z.Bao和F.Würthner,J.Am.Chem.Soc.2009,131,6215-6228描述了卤化的苝二酰亚胺衍生物,例如:
S.Nakazono,Y.Imazaki,H.Yoo,J.Yang,T.Sasamori,N.Tokitoh,T.Cédric,H.Kageyama,D.Kim,H.Shinokubo和A.Osuka,Chem.Eur.J.2009,15,7530-7533描述了由苝四甲酸二酰亚胺制备2,5,8,11-四烷基化的苝四甲酸二酰亚胺:
S.Nakanzono,S.Easwaramoorthi,D.Kim,H.Shinokubo,A.OsukaOrg.Lett.2009,11,5426-5429描述了由苝四甲酸二酰亚胺制备2,5,8,11-四芳基化的苝四甲酸二酰亚胺:
US7,355,198B2描述了一种有机薄膜晶体管(OFET),其在源电极和漏电极之间插入有机受体膜和有机半导体膜。所述有机半导体膜由并五苯形成。特别地,所述有机受体膜由至少一种选自一长列化合物的吸电子材料形成,所述化合物包括N,N’-双(二叔丁基苯基)-3,4,9,10-苝二甲酰亚胺。
US7,326,956B2描述了一种薄膜晶体管,其包括有机半导体材料层,所述有机半导体材料包含具有与各酰亚胺氮原子连接的且被一个或多个含氟基团取代的碳环或杂环芳族环体系的四甲酸二酰亚胺苝基化合物。在一个实施方案中,含氟N,N’-二芳基苝基四甲酸二酰亚胺化合物由下述结构表示:
其中A1和A2独立地为包含至少一个其中一个或多个氢原子被至少一个含氟基团取代的芳族环的碳环和/或杂环芳族环体系。苝核可任选被至多8个独立选择的X基团取代,其中n为0-8的整数。苝上的X取代基可包括一长列取代基,包括卤素如氟或氯。
WO2007/093643描述了氟化的萘嵌苯(rylene)四甲酸衍生物。优选的化合物为式IBa化合物:
其中基团R11、R12、R13、R14、R21、R22、R23和R24中的1、2、3、4、5或6个为F;
任选不为F的至少一个基团R11、R12、R13、R14、R21、R22、R23和R24可独立地为Cl或Br,且剩余基团为H;且
Ra和Rb彼此独立地为H或有机基团。
WO2008/063609描述了一种具有下式的化合物:
其中Q可为:
其中A、B、I、D、E、F、G和H独立地选自包括CH和CRa在内的取代基,其中Ra可选自一列取代基,包括卤素。例如,A、B、I、D、E、F、G和H可独立地为CH、C-Br或C-CN。
WO2009/024512描述了含卤苝四甲酸衍生物,尤其是化合物IBa:
其中基团R11、R12、R13、R14、R21、R22、R23和R24为Cl和/或F;
其中基团R11、R12、R13、R14、R21、R22、R23和R24中的1或2个可为CN,和/或其中基团R11、R12、R13、R14、R21、R22、R23和R24中的1个可为H,且Ra和Rb彼此独立地为H或有机基团。
G.Battagliari,C.Li,V.Enkelmann,K.Müllen,Org.Lett.2011,13,3012-3015描述了下式化合物:
G.Battagliari,Y.Zhao,C.Li,K.Müllen,Org.Lett.2011,13,3399-3401描述了下式化合物:
迄今为止,仍不能制备2,5,8,11-四氟苝双(二甲酰亚胺)。
本发明的目的是提供2,5,8,11-四氟苝双(二甲酰亚胺)。
所述目的由权利要求1的化合物、权利要求5的方法和权利要求6的电子器件实现。
本发明的苝基半导体化合物具有下式:
其中:
R1和R2彼此独立地选自H、任选被1-30个取代基Ra取代的C1-30烷基、任选被1-30个取代基Ra取代的C2-30链烯基、任选被1-30个取代基Ra取代的C2-30炔基、任选被1-10个取代基Rb取代的C3-10环烷基、任选被1-10个取代基Rb取代的C5-10环烯基、任选被1-8个取代基Rb取代的3-14元环杂烷基、任选被1-8个取代基Rc取代的C6-14芳基和任选被1-8个取代基Rc取代的5-14元杂芳基;
其中:
Ra在每次出现时彼此独立地选自卤素、-CN、-NO2、-N3、-OH、任选被1-6个取代基Ri取代的C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR3、任选被1-30个取代基Ri取代的-S-C1-30烷基、任选被1-30个取代基Ri取代的-SO2-C1-30烷基、-NH2、-NHR3、-NR3R4、-[NR3R4R5]+、-NH-COR3、-COOH、-COOR3、-CONH2、-CONHR3、-CONR3R4、-CO-H、-COR3、任选被1-10个取代基Rii取代的C3-10环烷基、任选被1-10个取代基Rii取代的C5-10环烯基、任选被1-10个取代基Rii取代的3-14元环杂烷基、任选被1-8个取代基Riii取代的C6-14芳基和任选被1-8个取代基Riii取代的5-14元杂芳基;
Rb在每次出现时彼此独立地选自卤素、-CN、-NO2、-OH、任选被1-30个取代基Ri取代的C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR3、任选被1-30个取代基Ri取代的-S-C1-30烷基、-NH2、-NHR3、-NR3R4、-[NR3R4R5]+、-NH-COR3、-COOH、-COOR3、-CONH2、-CONHR3、-CONR3R4、-CO-H、-COR3、任选被1-30个取代基Ri取代的C1-30烷基、任选被1-30个取代基Ri取代的C2-30链烯基、任选被1-30个取代基Ri取代的C2-30炔基、任选被1-10个取代基Rii取代的C3-10环烷基、任选被1-10个取代基Rii取代的C5-10环烯基、任选被1-10个取代基Rii取代的3-14元环杂烷基、任选被1-8个取代基Riii取代的C6-14芳基和任选被1-8个取代基Riii取代的5-14元杂芳基;
Rc在每次出现时彼此独立地选自卤素、-CN、-NO2、-N3、-OH、任选被1-30个取代基Ri取代的C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR3、任选被1-30个取代基Ri取代的-S-C1-30烷基、任选被1-30个取代基Ri取代的-SO2-C1-30烷基、-NH2、-NHR3、-NR3R4、-[NR3R4R5]+、-NH-COR3、-COOH、-COOR3、-CONH2、-CONHR3、-CONR3R4、-CO-H、-COR3、任选被1-30个取代基Ri取代的C1-30烷基、任选被1-30个取代基Ri取代的C2-30链烯基、任选被1-30个取代基Ri取代的C2-30炔基、任选被1-10个取代基Rii取代的C3-10环烷基、任选被1-10个取代基Rii取代的C5-10环烯基、任选被1-10个取代基Rii取代的3-14元环杂烷基、任选被1-8个取代基Riii取代的C6-14芳基和任选被1-8个取代基Riii取代的5-14元杂芳基;
其中:
R3、R4和R5在每次出现时彼此独立地选自任选被1-30个取代基Ri取代的C1-30烷基、任选被1-30个取代基Ri取代的C2-30链烯基、任选被1-30个取代基Ri取代的C2-30炔基、任选被1-10个取代基Rii取代的C3-10环烷基、任选被1-10个取代基Rii取代的C5-10环烯基、任选被1-10个取代基Rii取代的3-14元环杂烷基、任选被1-8个取代基Riii取代的C6-14芳基和任选被1-8个取代基Riii取代的5-14元杂芳基;
Ri在每次出现时彼此独立地选自卤素、-CN、-NO2、-N3、-OH、C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR3、-S-C1-30烷基、-SO2-C1-30烷基、-NH2、-NHR6、-NR6R7、-[NR6R7R8]+、-NH-COR6、-COOH、-COOR6、-CONH2、-CONHR6、-CONR6R7、-CO-H、-COR6、C3-10环烷基、C5-10环烯基、3-14元环杂烷基、C6-14芳基和5-14元杂芳基;
Rii在每次出现时彼此独立地选自卤素、-CN、-NO2、-OH、C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR6、-S-C1-30烷基、-NH2、-NHR6、-NR6R7、-[NR6R7R8]+、-NH-COR6、-COOH、-COOR6、-CONH2、-CONHR6、-CONR6R7、-CO-H、-COR6、C1-30烷基、C2-30链烯基、C2-30炔基、C3-10环烷基、C5-10环烯基、3-14元环杂烷基、C6-14芳基和5-14元杂芳基;
Riii在每次出现时彼此独立地选自卤素、-CN、-NO2、-N3、-OH、C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR6、-S-C1-30烷基、-SO2-C1-30烷基、-NH2、-NHR6、-NR6R7、-[NR6R7R8]+、-NH-COR6、-COOH、-COOR6、-CONH2、-CONHR6、-CONR6R7、-CO-H、-COR6、C1-30烷基、C2-30链烯基、C2-30炔基、C3-10环烷基、C5-10环烯基、3-14元环杂烷基、C6-14芳基和5-14元杂芳基;
其中:
R6、R7和R8在每次出现时彼此独立地选自C1-30烷基、C2-30链烯基、C2-30炔基、C3-10环烷基、C5-10环烯基、3-14元环杂烷基、C6-14芳基和5-14元杂芳基。
C1-10烷基和C1-30烷基可为支化的或未支化的。C1-10烷基的实例为甲基、乙基、正丙基、异丙基、正丁基、仲丁基、异丁基、叔丁基、正戊基、新戊基、异戊基、正(1-乙基)丙基、正己基、正庚基、正辛基、正(2-乙基)己基、正壬基和正癸基。C3-8烷基的实例为正丙基、异丙基、正丁基、仲丁基、异丁基、叔丁基、正戊基、新戊基、异戊基、正(1-乙基)丙基、正己基、正庚基、正辛基和正(2-乙基)己基。C1-30烷基的实例为C1-10烷基和正十一烷基、正十二烷基、正十三烷基、正十四烷基、正十五烷基、正十六烷基、正十七烷基、正十八烷基、正十九烷基和正二十烷基(C20)、正二十二烷基(C22)、正二十四烷基(C24)、正二十六烷基(C26)、正二十八烷基(C28)和正三十烷基(C30)。在与式I的N连接的C处支化的C3-25烷基的实例为异丙基、仲丁基、正(1-甲基)丙基、正(1-乙基)丙基、正(1-甲基)丁基、正(1-乙基)丁基、正(1-丙基)丁基、正(1-甲基)戊基、正(1-乙基)戊基、正(1-丙基)戊基、正(1-丁基)戊基、正(1-丁基)己基、正(1-戊基)己基、正(1-己基)庚基、正(1-庚基)辛基、正(1-辛基)壬基、正(1-壬基)癸基、正(1-癸基)十一烷基、正(1-十一烷基)十二烷基和正(1-十二烷基)十三烷基。
C2-30链烯基可为支化的或未支化的。C2-30链烯基的实例为乙烯基、丙烯基、顺-2-丁烯基、反-2-丁烯基、3-丁烯基、顺-2-戊烯基、反-2-戊烯基、顺-3-戊烯基、反-3-戊烯基、4-戊烯基、2-甲基-3-丁烯基、己烯基、庚烯基、辛烯基、壬烯基和癸烯基、亚油基(C18)、亚麻基(linolenyl,C18)、油基(C18)、花生四烯基(C20)和瓢儿菜基(C22)。
C2-30炔基可为支化的或未支化的。C2-30炔基的实例为乙炔基、2-丙炔基、2-丁炔基、3-丁炔基、戊炔基、己炔基、庚炔基、辛炔基、壬炔基和癸炔基、十一碳炔基、十二碳炔基、十一碳炔基、十二碳炔基、十三碳炔基、十四碳炔基、十五碳炔基、十六碳炔基、十七碳炔基、十八碳炔基、十九碳炔基和二十碳炔基(C20)。
C3-10环烷基的实例优选为单环C3-10环烷基如环丙基、环丁基、环戊基、环己基、环庚基和环辛基;还包括多环C3-10环烷基如十氢化萘基、降冰片基和金刚烷基。
C5-10环烯基的实例优选为单环C5-10环烯基如环戊烯基、环己烯基、环己二烯基和环庚三烯基,还包括多环C5-10环烯基。
3-14元环杂烷基的实例为单环3-8元环杂烷基和多环,例如双环7-12元环杂烷基。
单环3-8元环杂烷基的实例为包含一个杂原子的单环5元环杂烷基,如吡咯烷基、1-吡咯啉基、2-吡咯啉基、3-吡咯啉基、四氢呋喃基、2,3-二氢呋喃基、四氢噻吩基和2,3-二氢噻吩基;包含两个杂原子的单环5元环杂烷基,如咪唑烷基、咪唑啉基、吡唑烷基、吡唑啉基、唑烷基、唑啉基、异唑烷基、异唑啉基、噻唑烷基、噻唑啉基、异噻唑烷基和异噻唑啉基;包含三个杂原子的单环5元环杂烷基,如1,2,3-三唑基、1,2,4-三唑基和1,4,2-二噻唑基(dithiazoyl);包含1个杂原子的单环6元环杂烷基,如哌啶基、哌啶子基、四氢吡喃基、吡喃基、噻烷基(thianyl)和噻喃基;包含两个杂原子的单环6元环杂烷基,如哌嗪基、吗啉基、吗啉代和噻嗪基;包含一个杂原子的单环7元环杂烷基,如氮杂环庚烷基(azepanyl)、氮杂基(azepinyl)、氧杂环庚烷基(oxepanyl)、硫杂环庚烷基(thiepanyl)、噻环庚烷基(thiapanyl)、硫杂基(thiepinyl);以及包含两个杂原子的单环7元环杂烷基,如1,2-二氮杂基(diazepinyl)和1,3-硫氮杂基(thiazepinyl)。
双环7-12元环杂烷基的实例为十氢萘基。
C6-14芳基可为单环或多环的。C6-14芳基的实例为单环C6芳基,如苯基;双环C9-10芳基,如1-萘基、2-萘基、茚基、2,3-二氢化茚基和四氢萘基;以及三环C12-14芳基,如蒽基、菲基、芴基和s-二环戊二烯并苯基(s-indacenyl)。
5-14元杂芳基可为单环5-8元杂芳基或多环7-14元杂芳基,例如双环7-12元或三环9-14元杂芳基。
单环5-8元杂芳基的实例为包含一个杂原子的单环5元杂芳基,如吡咯基、呋喃基和噻吩基;包含两个杂原子的单环5元杂芳基,如咪唑基、吡唑基、唑基、异唑基、噻唑基、异噻唑基;包含三个杂原子的单环5元杂芳基,如1,2,3-三唑基、1,2,4-三唑基和二唑基;包含四个杂原子的单环5元杂芳基,如四唑基;包含一个杂原子的单环6元杂芳基,如吡啶基;包含两个杂原子的单环6元杂芳基,如吡嗪基、嘧啶基和哒嗪基;包含三个杂原子的6元杂芳基,如1,2,3-三嗪基、1,2,4-三嗪基和1,3,5-三嗪基;包含一个杂原子的单环7元杂芳基,如氮杂基;以及包含两个杂原子的单环7元杂芳基,如1,2-二氮杂基。
双环7-12元杂芳基的实例为包含一个杂原子的双环9元杂芳基,如吲哚基、异吲哚基、中氮茚基、二氢吲哚基、苯并呋喃基、异苯并呋喃基、苯并噻吩基和异苯并噻吩基;包含两个杂原子的双环9元杂芳基,如吲唑基、苯并咪唑基、苯并咪唑啉基、苯并唑基、苯并异唑基、苯并噻唑基、苯并异噻唑基、呋喃并吡啶基和噻吩并吡啶基;包含三个杂原子的双环9元杂芳基,如苯并三唑基、苯并二唑基、唑并吡啶基、异唑并吡啶基、噻唑并吡啶基、异噻唑并吡啶基和咪唑并吡啶基;包含四个杂原子的双环9元杂芳基,如嘌呤基;包含一个杂原子的双环10元杂芳基,如喹啉基、异喹啉基、苯并吡喃基和苯并二氢吡喃基;包含两个杂原子的双环10元杂芳基,如喹喔啉基、喹唑啉基、噌啉基、2,3-二氮杂萘基、1,5-二氮杂萘基和1,8-二氮杂萘基;包含三个杂原子的双环10元杂芳基,如吡啶并吡嗪基、吡啶并嘧啶基和吡啶并哒嗪基;以及包含四个杂原子的双环10元杂芳基,如蝶啶基。
卤素的实例为-F、-Cl、-Br和-I。
C1-30烷氧基的实例为甲氧基、乙氧基、正丙氧基、异丙氧基、正丁氧基、仲丁氧基、异丁氧基、叔丁氧基、正戊氧基、新戊氧基、异戊氧基、己氧基、正庚氧基、正辛氧基、正壬氧基、正癸氧基、正十一烷氧基、正十二烷氧基、正十三烷氧基、正十四烷氧基、正十五烷氧基、正十六烷氧基、正十七烷氧基、正十八烷氧基和正十九烷氧基。
C2-5亚烷基的实例亚乙基、亚丙基、亚丁基和亚戊基。
优选地,
R1和R2彼此独立地选自H、任选被1-30个取代基Ra取代的C1-30烷基、任选被1-30个取代基Ra取代的C2-30链烯基、任选被1-10个取代基Rb取代的C3-10环烷基和任选被1-8个取代基Rc取代的C6-14芳基;
其中:
Ra在每次出现时彼此独立地选自卤素、-CN、-NO2、-N3、-OH、任选被1-6个取代基Ri取代的C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR3、任选被1-30个取代基Ri取代的-S-C1-30烷基、任选被1-30个取代基Ri取代的-SO2-C1-30烷基、-NH2、-NHR3、-NR3R4、-[NR3R4R5]+、-NH-COR3、-COOH、-COOR3、-CONH2、-CONHR3、-CONR3R4、-CO-H、-COR3、任选被1-10个取代基Rii取代的C3-10环烷基和任选被1-8个取代基Riii取代的C6-14芳基;
Rb在每次出现时彼此独立地选自卤素、-CN、-NO2、-OH、任选被1-30个取代基Ri取代的C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR3、任选被1-30个取代基Ri取代的-S-C1-30烷基、-NH2、-NHR3、-NR3R4、-[NR3R4R5]+、-NH-COR3、-COOH、-COOR3、-CONH2、-CONHR3、-CONR3R4、-CO-H、-COR3、任选被1-30个取代基Ri取代的C1-30烷基、任选被1-30个取代基Ri取代的C2-30链烯基、任选被1-10个取代基Rii取代的C3-10环烷基和任选被1-8个取代基Riii取代的C6-14芳基;
Rc在每次出现时彼此独立地选自卤素、-CN、-NO2、-N3、-OH、任选被1-30个取代基Ri取代的C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR3、任选被1-30个取代基Ri取代的-S-C1-30烷基、任选被1-30个取代基Ri取代的-SO2-C1-30烷基、-NH2、-NHR3、-NR3R4、-[NR3R4R5]+、-NH-COR3、-COOH、-COOR3、-CONH2、-CONHR3、-CONR3R4、-CO-H、-COR3、任选被1-30个取代基Ri取代的C1-30烷基、任选被1-30个取代基Ri取代的C2-30链烯基、任选被1-10个取代基Rii取代的C3-10环烷基和任选被1-8个取代基Riii取代的C6-14芳基;其中:
R3、R4和R5在每次出现时彼此独立地选自任选被1-30个取代基Ri取代的C1-30烷基、任选被1-30个取代基Ri取代的C2-30链烯基、任选被1-10个取代基Rii取代的C3-10环烷基和任选被1-8个取代基Riii取代的C6-14芳基;
Ri在每次出现时彼此独立地选自卤素、-CN、-NO2、-N3、-OH、C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR3、-S-C1-30烷基、-SO2-C1-30烷基、-NH2、-NHR6、-NR6R7、-[NR6R7R8]+、-NH-COR6、-COOH、-COOR6、-CONH2、-CONHR6、-CONR6R7、-CO-H、-COR6、C3-10环烷基和C6-14芳基;
Rii在每次出现时彼此独立地选自卤素、-CN、-NO2、-OH、C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR6、-S-C1-30烷基、-NH2、-NHR6、-NR6R7、-[NR6R7R8]+、-NH-COR6、-COOH、-COOR6、-CONH2、-CONHR6、-CONR6R7、-CO-H、-COR6、C1-30烷基、C2-30链烯基、C3-10环烷基和C6-14芳基;
Riii在每次出现时彼此独立地选自卤素、-CN、-NO2、-N3、-OH、C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR6、-S-C1-30烷基、-SO2-C1-30烷基、-NH2、-NHR6、-NR6R7、-[NR6R7R8]+、-NH-COR6、-COOH、-COOR6、-CONH2、-CONHR6、-CONR6R7、-CO-H、-COR6、C1-30烷基、C2-30链烯基、C3-10环烷基和C6-14芳基;
其中:
R6、R7和R8在每次出现时彼此独立地选自C1-30烷基、C2-30链烯基、C3-10环烷基和C6-14芳基。
更优选地,
R1和R2彼此独立地为任选被1-30个取代基Ra取代的C1-30烷基;
其中:
Ra在每次出现时彼此独立地选自卤素、-CN、-NO2、-N3、-OH、任选被1-6个取代基Ri取代的C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR3、任选被1-30个取代基Ri取代的-S-C1-30烷基、任选被1-30个取代基Ri取代的-SO2-C1-30烷基、-NH2、-NHR3、-NR3R4、-[NR3R4R5]+、-NH-COR3、-COOH、-COOR3、-CONH2、-CONHR3、-CONR3R4、-CO-H、-COR3、任选被1-10个取代基Rii取代的C3-10环烷基和任选被1-8个取代基Riii取代的C6-14芳基;
其中:
R3、R4和R5在每次出现时彼此独立地选自任选被1-30个取代基Ri取代的C1-30烷基、任选被1-30个取代基Ri取代的C2-30链烯基、任选被1-10个取代基Rii取代的C3-10环烷基和任选被1-8个取代基Riii取代的C6-14芳基;
Ri在每次出现时彼此独立地选自卤素、-CN、-NO2、-N3、-OH、C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR3、-S-C1-30烷基、-NH2、-NHR6、-SO2-C1-30烷基、-NR6R7、-[NR6R7R8]+、-NH-COR6、-COOH、-COOR6、-CONH2、-CONHR6、-CONR6R7、-CO-H、-COR6、C3-10环烷基和C6-14芳基;
Rii在每次出现时彼此独立地选自卤素、-CN、-NO2、-OH、C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR6、-S-C1-30烷基、-NH2、-NHR6、-NR6R7、-[NR6R7R8]+、-NH-COR6、-COOH、-COOR6、-CONH2、-CONHR6、-CONR6R7、-CO-H、-COR6、C1-30烷基、C2-30链烯基、C3-10环烷基和C6-14芳基;
Riii在每次出现时彼此独立地选自卤素、-CN、-NO2、-N3、-OH、C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR6、-S-C1-30烷基、-SO2-C1-30烷基、-NH2、-NHR6、-NR6R7、-[NR6R7R8]+、-NH-COR6、-COOH、-COOR6、-CONH2、-CONHR6、-CONR6R7、-CO-H、-COR6、C1-30烷基、C2-30链烯基、C3-10环烷基和C6-14芳基;
其中:
R6、R7和R8在每次出现时彼此独立地选自C1-30烷基、C2-30链烯基、C3-10环烷基和C6-14芳基。
最优选地,
R1和R2彼此独立地为在与式1的N连接的C处支化的C3-25烷基。
特别优选下式化合物:
本发明的一部分还为一种制备下式化合物的方法:
其中R1和R2如上文所定义;
所述方法包括如下步骤:
(i)用氟化物源处理式(5)化合物:
其中R1和R2如上文所定义,且X为Cl、Br或I。
所述氟化物源可为碱金属氟化物(alkali fluoride),如氟化钾。氟化物源/式(5)化合物的摩尔当量之比通常为1/1-30/1,优选为10/1-30/1。
所述反应通常在100-200℃,优选130-180℃的温度下进行。所述反应通常在密封的反应容器中进行。
X优选为Cl。
式(5)化合物可如G.Battagliari,C.Li,V.Enkelmann,K.Müllen,Org.Lett.2011,13,3012-3015和G.Battagliari,Y.Zhao,C.Li,K.Müllen,Org.Lett.2011,13,3399-3401所述制备。
式(1)化合物可通过本领域已知的方法如柱层析分离。
本发明的一部分还为一种电子器件,其包含式(1)化合物作为半导体材料。优选地,所述电子器件为有机场效应晶体管(OFET)。
有机场效应晶体管通常包括介电层、半导体层和衬底。此外,有机场效应晶体管通常包括栅电极和源/漏电极。
有机场效应晶体管可具有各种设计。
有机场效应晶体管的最常见设计是底栅极设计。底栅极设计的实例示于图1中。
有机场效应晶体管的另一设计是顶栅极设计。顶栅极设计的实例示于图2中。
所述半导体层包含本发明的半导体材料。所述半导体层可具有5-500nm,优选10-100nm,更优选20-50nm的厚度。
所述介电层包含介电材料。所述介电材料可为二氧化硅,或有机聚合物如聚苯乙烯(PS)、聚甲基丙烯酸甲酯(PMMA)、聚(4-乙烯基苯酚)(PVP)、聚乙烯醇(PVA)、苯并环丁烯(BCB)或聚酰亚胺(PI)。所述介电层可具有10-2000nm,优选50-1000nm,更优选100-800nm的厚度。
所述源/漏电极可由任何合适的源/漏极材料制成,例如金(Au)或钽(Ta)。所述源/漏电极可具有1-100nm,优选5-50nm的厚度。
所述栅电极可由任何合适的栅极材料制成,例如高度掺杂的硅、铝(Al)、钨(W)、氧化铟锡、金(Au)和/或钽(Ta)。所述栅电极可具有1-200nm,优选5-100nm的厚度。
所述衬底可为任何合适的衬底,如玻璃,或塑料衬底如聚醚砜、聚碳酸酯、聚砜、聚对苯二甲酸乙二醇酯(PET)和聚萘二甲酸乙二醇酯(PEN)。取决于有机场效应晶体管的设计,栅电极和介电层的组合也可起衬底作用。
所述有机场效应晶体管可通过本领域已知的方法制备。
例如,底栅极有机场效应晶体管可如下制备:
栅电极可通过将栅极材料如高度掺杂的硅沉积在由合适介电材料如二氧化硅制成的介电层的一侧上而形成。所述介电层的另一侧可任选用合适的试剂,例如用六甲基二硅氮烷(HMDS)处理。可例如通过气相沉积合适的源/漏电材料,例如钽(Ta)和/或金(Au)而将源/漏电极沉积至所述介电层的该侧(任选用合适试剂处理的一侧)。然后,可通过溶液加工,例如滴涂本发明半导体材料在合适溶剂,例如在氯仿中的溶液而用半导体层覆盖该源/漏电极。
本发明的一部分还为式(1)化合物作为半导体材料的用途。
图1显示了底栅极有机场效应晶体管的两种设计。
图2显示了顶栅极有机场效应晶体管的两种设计。
本发明半导体材料的优点在于,这些材料在溶剂中的高溶解度适于溶液加工。此外,本发明的半导体材料显示出可接受的载流子迁移率。
实施例
实施例1
制备N,N’-双(1-庚基辛基)-2,5,8,11-四[4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基]苝-3,4:9,10-四甲酸二酰亚胺(4a)
将N,N’-双(1-庚基辛基)苝-3,4:9,10-四甲酸二酰亚胺(2a)(100mg,0.12mmol)和双频哪酮二硼酸酯(3a)(250mg,0.99mmol)混合在一起并溶于1mL无水和1mL无水频哪酮中。使氩气鼓泡通过该溶液达30分钟。向该混合物中添加RuH2(CO)(PPh3)3(23mg,0.03mmol)并将该反应混合物在140℃下加热30小时。在将该体系冷却至室温后,蒸发溶剂并通过柱层析(CH2Cl2)提纯所需的化合物。以70%的产率(113mg,0.09mmol)获得呈红色固体的4a。
1H NMR(250MHz,CD2Cl2):δ8.58(s,4H),5.06(s,2H),2.35-2.06(m,4H),1.98-1.72(m,4H),1.50(s,48H),1.24(s,40H),0.84(t,J=6.5Hz,12H)。13C NMR(126MHz,CD2Cl2):δ166.27(d,J=98.5Hz),139.79-138.86(m),133.80(s),128.82(s),127.57(d,J=69.0Hz),127.30(s),126.29(s),84.90(s),55.19(s),32.83(s),32.45(s),30.03(s),29.76(s),27.37(s),25.38(s),23.22(s),14.43(s)。FD/MS(8kV):m/z=1312.4(100%)[M+]。UV-Vis(在甲苯中):λ最大(ε[M-1cm-1]):538nm(5.57×104)。荧光(在甲苯中,λex=538nm):548nm。ΦF:0.83。元素分析:理论值:C:71.24%;H:8.74%;N:2.13%;实验值:C:70.76%;H:8.27%;N:2.50%。
实施例2
制备N,N’-双(1-庚基辛基)-2,5,8,11-四氯苝-3,4:9,10-四甲酸二酰亚胺(5a)
将如实施例1所述制备的N,N’-双(1-庚基辛基)-2,5,8,11-四[4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基]苝-3,4:9,10-四甲酸二酰亚胺(4a)(1.00g,0.76mmol)和氯化铜(II)(1.23g,9.13mmol)悬浮于甲醇(3mL)和水(3mL)的混合物中,并在密闭容器中于100℃下加热6小时。然后,将该反应混合物倾入水中,并用二氯甲烷萃取。将有机相在硫酸镁上干燥并蒸发溶剂。在柱层析(二氧化硅,二氯甲烷)之后,以87%产率(0.628g,0.66mmol)获得呈橙色固体的化合物5a。
1H NMR(250MHz,CD2Cl2):δ8.43(s,4H),5.06(m,2H),2.22-1.99(m,4H),1.79(m,4H),1.20(m,40H),0.82-0.69(m,12H)。FD质谱(8kV):m/z=947.7(100%)[M+]。
实施例3
制备N,N’-双(1-庚基辛基)-2,5,8,11-四氟苝-3,4:9,10-四甲酸二酰亚胺(1a)
将如实施例2所述制备的N,N’-双(1-庚基辛基)-2,5,8,11-四氯苝-3,4:9,10-四甲酸二酰亚胺(5a)(50mg,0.05mmol)和氟化钾(61mg,1.05mmol)悬浮于二烷(2mL)和二甘醇二甲醚(1mL)的混合物中,并在微波炉中于密闭容器中于150℃下加热20小时。然后将所述反应混合物冷却,移除溶剂,剩余固体通过柱层析(硅胶,二氯甲烷/石油醚2/1)提纯。以30%产率(13mg,0.02mmol)获得呈黄色固体的化合物1a。
1H NMR(250MHz,CD2Cl2):δ8.23(d,J=12.4Hz,4H),5.15(m,2H),2.18(m,4H),1.82(m,4H),1.25(m,40H),0.92-0.73(m,12H)。FD质谱(8kV):m/z=947.7(100%)[M+]。UV-VIS(在二氯甲烷中):λ最大:500nm。荧光(在二氯甲烷中,λ最大:500nm):509nm。
Claims (7)
1.一种下式化合物:
其中:
R1和R2彼此独立地选自H、任选被1-30个取代基Ra取代的C1-30烷基、任选被1-30个取代基Ra取代的C2-30链烯基、任选被1-30个取代基Ra取代的C2-30炔基、任选被1-10个取代基Rb取代的C3-10环烷基、任选被1-10个取代基Rb取代的C5-10环烯基、任选被1-8个取代基Rb取代的3-14元环杂烷基、任选被1-8个取代基Rc取代的C6-14芳基和任选被1-8个取代基Rc取代的5-14元杂芳基;
其中:
Ra在每次出现时彼此独立地选自卤素、-CN、-NO2、-N3、-OH、任选被1-6个取代基Ri取代的C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR3、任选被1-30个取代基Ri取代的-S-C1-30烷基、任选被1-30个取代基Ri取代的-SO2-C1-30烷基、-NH2、-NHR3、-NR3R4、-[NR3R4R5]+、-NH-COR3、-COOH、-COOR3、-CONH2、-CONHR3、-CONR3R4、-CO-H、-COR3、任选被1-10个取代基Rii取代的C3-10环烷基、任选被1-10个取代基Rii取代的C5-10环烯基、任选被1-10个取代基Rii取代的3-14元环杂烷基、任选被1-8个取代基Riii取代的C6-14芳基和任选被1-8个取代基Riii取代的5-14元杂芳基;
Rb在每次出现时彼此独立地选自卤素、-CN、-NO2、-OH、任选被1-30个取代基Ri取代的C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR3、任选被1-30个取代基Ri取代的-S-C1-30烷基、-NH2、-NHR3、-NR3R4、-[NR3R4R5]+、-NH-COR3、-COOH、-COOR3、-CONH2、-CONHR3、-CONR3R4、-CO-H、-COR3、任选被1-30个取代基Ri取代的C1-30烷基、任选被1-30个取代基Ri取代的C2-30链烯基、任选被1-30个取代基Ri取代的C2-30炔基、任选被1-10个取代基Rii取代的C3-10环烷基、任选被1-10个取代基Rii取代的C5-10环烯基、任选被1-10个取代基Rii取代的3-14元环杂烷基、任选被1-8个取代基Riii取代的C6-14芳基和任选被1-8个取代基Riii取代的5-14元杂芳基;
Rc在每次出现时彼此独立地选自卤素、-CN、-NO2、-N3、-OH、任选被1-30个取代基Ri取代的C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR3、任选被1-30个取代基Ri取代的-S-C1-30烷基、任选被1-30个取代基Ri取代的-SO2-C1-30烷基、-NH2、-NHR3、-NR3R4、-[NR3R4R5]+、-NH-COR3、-COOH、-COOR3、-CONH2、-CONHR3、-CONR3R4、-CO-H、-COR3、任选被1-30个取代基Ri取代的C1-30烷基、任选被1-30个取代基Ri取代的C2-30链烯基、任选被1-30个取代基Ri取代的C2-30炔基、任选被1-10个取代基Rii取代的C3-10环烷基、任选被1-10个取代基Rii取代的C5-10环烯基、任选被1-10个取代基Rii取代的3-14元环杂烷基、任选被1-8个取代基Riii取代的C6-14芳基和任选被1-8个取代基Riii取代的5-14元杂芳基;
其中:
R3、R4和R5在每次出现时彼此独立地选自任选被1-30个取代基Ri取代的C1-30烷基、任选被1-30个取代基Ri取代的C2-30链烯基、任选被1-30个取代基Ri取代的C2-30炔基、任选被1-10个取代基Rii取代的C3-10环烷基、任选被1-10个取代基Rii取代的C5-10环烯基、任选被1-10个取代基Rii取代的3-14元环杂烷基、任选被1-8个取代基Riii取代的C6-14芳基和任选被1-8个取代基Riii取代的5-14元杂芳基;
Ri在每次出现时彼此独立地选自卤素、-CN、-NO2、-N3、-OH、C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR3、-S-C1-30烷基、-SO2-C1-30烷基、-NH2、-NHR6、-NR6R7、-[NR6R7R8]+、-NH-COR6、-COOH、-COOR6、-CONH2、-CONHR6、-CONR6R7、-CO-H、-COR6、C3-10环烷基、C5-10环烯基、3-14元环杂烷基、C6-14芳基和5-14元杂芳基;
Rii在每次出现时彼此独立地选自卤素、-CN、-NO2、-OH、C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR6、-S-C1-30烷基、-NH2、-NHR6、-NR6R7、-[NR6R7R8]+、-NH-COR6、-COOH、-COOR6、-CONH2、-CONHR6、-CONR6R7、-CO-H、-COR6、C1-30烷基、C2-30链烯基、C2-30炔基、C3-10环烷基、C5-10环烯基、3-14元环杂烷基、C6-14芳基和5-14元杂芳基;
Riii在每次出现时彼此独立地选自卤素、-CN、-NO2、-N3、-OH、C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR6、-S-C1-30烷基、-SO2-C1-30烷基、-NH2、-NHR6、-NR6R7、-[NR6R7R8]+、-NH-COR6、-COOH、-COOR6、-CONH2、-CONHR6、-CONR6R7、-CO-H、-COR6、C1-30烷基、C2-30链烯基、C2-30炔基、C3-10环烷基、C5-10环烯基、3-14元环杂烷基、C6-14芳基和5-14元杂芳基;
其中:
R6、R7和R8在每次出现时彼此独立地选自C1-30烷基、C2-30链烯基、C2-30炔基、C3-10环烷基、C5-10环烯基、3-14元环杂烷基、C6-14芳基和5-14元杂芳基。
2.根据权利要求1的化合物,其中:
R1和R2彼此独立地选自H、任选被1-30个取代基Ra取代的C1-30烷基、任选被1-30个取代基Ra取代的C2-30链烯基、任选被1-10个取代基Rb取代的C3-10环烷基和任选被1-8个取代基Rc取代的C6-14芳基;
其中:
Ra在每次出现时彼此独立地选自卤素、-CN、-NO2、-N3、-OH、任选被1-6个取代基Ri取代的C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR3、任选被1-30个取代基Ri取代的-S-C1-30烷基、任选被1-30个取代基Ri取代的-SO2-C1-30烷基、-NH2、-NHR3、-NR3R4、-[NR3R4R5]+、-NH-COR3、-COOH、-COOR3、-CONH2、-CONHR3、-CONR3R4、-CO-H、-COR3、任选被1-10个取代基Rii取代的C3-10环烷基和任选被1-8个取代基Riii取代的C6-14芳基;
Rb在每次出现时彼此独立地选自卤素、-CN、-NO2、-OH、任选被1-30个取代基Ri取代的C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR3、任选被1-30个取代基Ri取代的-S-C1-30烷基、-NH2、-NHR3、-NR3R4、-[NR3R4R5]+、-NH-COR3、-COOH、-COOR3、-CONH2、-CONHR3、-CONR3R4、-CO-H、-COR3、任选被1-30个取代基Ri取代的C1-30烷基、任选被1-30个取代基Ri取代的C2-30链烯基、任选被1-10个取代基Rii取代的C3-10环烷基和任选被1-8个取代基Riii取代的C6-14芳基;
Rc在每次出现时彼此独立地选自卤素、-CN、-NO2、-N3、-OH、任选被1-30个取代基Ri取代的C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR3、任选被1-30个取代基Ri取代的-S-C1-30烷基、任选被1-30个取代基Ri取代的-SO2-C1-30烷基、-NH2、-NHR3、-NR3R4、-[NR3R4R5]+、-NH-COR3、-COOH、-COOR3、-CONH2、-CONHR3、-CONR3R4、-CO-H、-COR3、任选被1-30个取代基Ri取代的C1-30烷基、任选被1-30个取代基Ri取代的C2-30链烯基、任选被1-10个取代基Rii取代的C3-10环烷基和任选被1-8个取代基Riii取代的C6-14芳基;
其中:
R3、R4和R5在每次出现时彼此独立地选自任选被1-30个取代基Ri取代的C1-30烷基、任选被1-30个取代基Ri取代的C2-30链烯基、任选被1-10个取代基Rii取代的C3-10环烷基和任选被1-8个取代基Riii取代的C6-14芳基;
Ri在每次出现时彼此独立地选自卤素、-CN、-NO2、-N3、-OH、C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR3、-S-C1-30烷基、-SO2-C1-30烷基、-NH2、-NHR6、-NR6R7、-[NR6R7R8]+、-NH-COR6、-COOH、-COOR6、-CONH2、-CONHR6、-CONR6R7、-CO-H、-COR6、C3-10环烷基和C6-14芳基;
Rii在每次出现时彼此独立地选自卤素、-CN、-NO2、-OH、C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR6、-S-C1-30烷基、-NH2、-NHR6、-NR6R7、-[NR6R7R8]+、-NH-COR6、-COOH、-COOR6、-CONH2、-CONHR6、-CONR6R7、-CO-H、-COR6、C1-30烷基、C2-30链烯基、C3-10环烷基和C6-14芳基;
Riii在每次出现时彼此独立地选自卤素、-CN、-NO2、-N3、-OH、C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR6、-S-C1-30烷基、-SO2-C1-30烷基、-NH2、-NHR6、-NR6R7、-[NR6R7R8]+、-NH-COR6、-COOH、-COOR6、-CONH2、-CONHR6、-CONR6R7、-CO-H、-COR6、C1-30烷基、C2-30链烯基、C3-10环烷基和C6-14芳基;
其中:
R6、R7和R8在每次出现时彼此独立地选自C1-30烷基、C2-30链烯基、C3-10环烷基和C6-14芳基。
3.根据权利要求1的化合物,其中:
R1和R2彼此独立地为任选被1-30个取代基Ra取代的C1-30烷基;
其中:
Ra在每次出现时彼此独立地选自卤素、-CN、-NO2、-N3、-OH、任选被1-6个取代基Ri取代的C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR3、任选被1-30个取代基Ri取代的-S-C1-30烷基、任选被1-30个取代基Ri取代的-SO2-C1-30烷基、-NH2、-NHR3、-NR3R4、-[NR3R4R5]+、-NH-COR3、-COOH、-COOR3、-CONH2、-CONHR3、-CONR3R4、-CO-H、-COR3、任选被1-10个取代基Rii取代的C3-10环烷基和任选被1-8个取代基Riii取代的C6-14芳基;
其中:
R3、R4和R5在每次出现时彼此独立地选自任选被1-30个取代基Ri取代的C1-30烷基、任选被1-30个取代基Ri取代的C2-30链烯基、任选被1-10个取代基Rii取代的C3-10环烷基和任选被1-8个取代基Riii取代的C6-14芳基;Ri在每次出现时彼此独立地选自卤素、-CN、-NO2、-N3、-OH、C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR3、-S-C1-30烷基、-SO2-C1-30烷基、-NH2、-NHR6、-NR6R7、-[NR6R7R8]+、-NH-COR6、-COOH、-COOR6、-CONH2、-CONHR6、-CONR6R7、-CO-H、-COR6、C3-10环烷基和C6-14芳基;
Rii在每次出现时彼此独立地选自卤素、-CN、-NO2、-OH、C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR6、-S-C1-30烷基、-NH2、-NHR6、-NR6R7、-[NR6R7R8]+、-NH-COR6、-COOH、-COOR6、-CONH2、-CONHR6、-CONR6R7、-CO-H、-COR6、C1-30烷基、C2-30链烯基、C3-10环烷基和C6-14芳基;
Riii在每次出现时彼此独立地选自卤素、-CN、-NO2、-N3、-OH、C1-30烷氧基、-O-[CH2CH2O]n-C1-10烷基(n=1-10)、-O-[CH2CH2O]m-OH(m=1-10)、-O-COR6、-S-C1-30烷基、-SO2-C1-30烷基、-NH2、-NHR6、-NR6R7、-[NR6R7R8]+、-NH-COR6、-COOH、-COOR6、-CONH2、-CONHR6、-CONR6R7、-CO-H、-COR6、C1-30烷基、C2-30链烯基、C3-10环烷基和C6-14芳基;
其中:
R6、R7和R8在每次出现时彼此独立地选自C1-30烷基、C2-30链烯基、C3-10环烷基和C6-14芳基。
4.根据权利要求1的化合物,其中:
R1和R2彼此独立地为在与式1的N连接的C处支化的C3-25烷基。
6.一种电子器件,包含根据权利要求1-4中任一项的式(1)化合物作为半导体材料。
7.根据权利要求1-4中任一项的式(1)化合物作为半导体材料的用途。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161522705P | 2011-08-12 | 2011-08-12 | |
US61/522705 | 2011-08-12 | ||
EP11177404 | 2011-08-12 | ||
EP11177404.8 | 2011-08-12 | ||
PCT/EP2012/065684 WO2013024026A1 (en) | 2011-08-12 | 2012-08-10 | Fluorinated perylene-based semiconducting materials |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103764787A true CN103764787A (zh) | 2014-04-30 |
Family
ID=47714796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201280037496.9A Pending CN103764787A (zh) | 2011-08-12 | 2012-08-10 | 氟化苝基半导体材料 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP2742111A1 (zh) |
JP (1) | JP2014529593A (zh) |
KR (1) | KR20140058621A (zh) |
CN (1) | CN103764787A (zh) |
WO (1) | WO2013024026A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2742112B1 (en) | 2011-08-12 | 2016-05-18 | Basf Se | Carbazolocarbazol-bis(dicarboximides) and their use as semiconductors |
EP2960280A1 (en) * | 2014-06-26 | 2015-12-30 | E.T.C. S.r.l. | Photocrosslinkable compositions, patterned high k thin film dielectrics and related devices |
KR102303315B1 (ko) | 2016-05-25 | 2021-09-23 | 주식회사 클랩 | 반도체 |
JP7464397B2 (ja) | 2020-01-31 | 2024-04-09 | 保土谷化学工業株式会社 | ペリレン誘導体化合物、該化合物を用いた有機半導体用組成物、該有機半導体用組成物を用いた有機薄膜トランジスタ |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090166614A1 (en) * | 2006-02-17 | 2009-07-02 | Basf Aktiengesellschaft | Fluorinated rylenetetracarboxylic acid derivatives and use thereof |
US20110068328A1 (en) * | 2007-08-17 | 2011-03-24 | Basf Se | Halogen-containing perylenetetracarboxylic acid derivatives and the use thereof |
WO2011052719A1 (ja) * | 2009-10-29 | 2011-05-05 | 大日精化工業株式会社 | ペリレンテトラカルボキシジイミド誘導体 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100615216B1 (ko) | 2004-04-29 | 2006-08-25 | 삼성에스디아이 주식회사 | 유기 억셉터막을 구비한 유기 박막 트랜지스터 |
US7326956B2 (en) | 2004-12-17 | 2008-02-05 | Eastman Kodak Company | Fluorine-containing N,N′-diaryl perylene-based tetracarboxylic diimide compounds as N-type semiconductor materials for thin film transistors |
EP2086974B1 (en) | 2006-11-17 | 2013-07-24 | Polyera Corporation | Diimide-based semiconductor materials and methods of preparing and using the same |
-
2012
- 2012-08-10 EP EP12747919.4A patent/EP2742111A1/en not_active Withdrawn
- 2012-08-10 JP JP2014525411A patent/JP2014529593A/ja active Pending
- 2012-08-10 KR KR1020147006179A patent/KR20140058621A/ko not_active Application Discontinuation
- 2012-08-10 WO PCT/EP2012/065684 patent/WO2013024026A1/en active Application Filing
- 2012-08-10 CN CN201280037496.9A patent/CN103764787A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090166614A1 (en) * | 2006-02-17 | 2009-07-02 | Basf Aktiengesellschaft | Fluorinated rylenetetracarboxylic acid derivatives and use thereof |
US20110068328A1 (en) * | 2007-08-17 | 2011-03-24 | Basf Se | Halogen-containing perylenetetracarboxylic acid derivatives and the use thereof |
WO2011052719A1 (ja) * | 2009-10-29 | 2011-05-05 | 大日精化工業株式会社 | ペリレンテトラカルボキシジイミド誘導体 |
Non-Patent Citations (2)
Title |
---|
GLAUCO BATTAGLIARIN ET AL.: "Efficient Tuning of LUMO Levels of 2,5,8,11-Substituted Perylenediimides via Copper Catalyzed Reactions", 《ORGANIC LETTERS》 * |
RUDIGER SCHMIDT ET AL.: "High-Performance Air-Stable n-Channel Organic Thin Film Transistors Based on Halogenated Perylene Bisimide Semiconductors", 《J. AM. CHEM. SOC.》 * |
Also Published As
Publication number | Publication date |
---|---|
KR20140058621A (ko) | 2014-05-14 |
JP2014529593A (ja) | 2014-11-13 |
WO2013024026A1 (en) | 2013-02-21 |
EP2742111A1 (en) | 2014-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102417717B1 (ko) | 결정질 유기 반도체 물질을 제조하는 방법 | |
CN103415517B (zh) | 氰硫基或异氰硫基取代的萘二酰亚胺和萘嵌苯二酰亚胺化合物及其作为n-型半导体的用途 | |
EP2022105A1 (en) | Method for producing organic field-effect transistors | |
EP3224246A1 (en) | 4-oxoquinoline compounds | |
CN103732720B (zh) | 卤代苝基半导体材料 | |
CN103492452B (zh) | 基于二酮基哌啶并哌啶共聚物的半导体材料 | |
CN103764787A (zh) | 氟化苝基半导体材料 | |
CN103492451A (zh) | 基于噻吩并噻吩-2,5-二酮低聚物和聚合物的半导体材料 | |
JP2009302470A (ja) | 有機トランジスタ | |
CN103492387A (zh) | 苝基半导体材料 | |
JP6234602B2 (ja) | 新規シクラジン、及びその半導体としての使用 | |
CN103415522B (zh) | 四氮杂靴二蒽化合物及其作为n-型半导体的用途 | |
CN103347883A (zh) | 四氮杂芘化合物及其作为n-型半导体的用途 | |
CN103517936A (zh) | 基于二噻吩并吡啶酮共聚物的半导体材料 | |
EP3224247A1 (en) | 4-hydroxyquinoline compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140430 |